Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients.
about
Staging lymph node metastases from lung cancer in the mediastinumMicrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implicationsProgression of cutaneous melanoma: implications for treatmentThe landscape of metastatic progression patterns across major human cancersIsolated tumor cells in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survivalDSG3 as a biomarker for the ultrasensitive detection of occult lymph node metastasis in oral cancer using nanostructured immunoarraysUnique patterns of metastases in common and rare types of malignancy.Role of selective sentinel lymph node dissection in head and neck melanoma.Interaction of tumor cells and lymphatic vessels in cancer progression.Epigenetics of regional lymph node metastasis in solid tumors.Improved computer-assisted analysis of the global lymphatic network in human cervical tissues.Lymphatics, lymph nodes and the immune system: barriers and gateways for cancer spread.CCL3 Enhances Antitumor Immune Priming in the Lymph Node via IFNγ with Dependency on Natural Killer Cells.Fluorescent radiocolloids: are hybrid tracers the future for lymphatic mapping?Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial.Intranodal Mapping Using Carbon Dye Results in More Accurate Lymph Node Staging in Colon Cancer Patients.Pulmonary Tumor Embolism Due to Squamous Cell Carcinoma of the Uterine Cervix: A Case Report.
P2860
Q26863443-998EA266-D4F3-4DB1-8EA5-1A0DD9A15FABQ26996059-320DD70D-B224-4944-8C41-ADFF61FBC156Q27001734-F1038FF6-A040-497E-B787-E20FDF60C714Q35238521-D06F14B9-E2DC-4C70-8338-C5E37B95780EQ35924171-03F7B122-F2C0-4271-BA03-0FB6C24D59F0Q36536575-3441430E-CC1F-4B45-B906-FDC8D02499CAQ37863635-79E9D050-DBF3-4859-B158-678DAB7C70E0Q37920831-5BA7AAF9-08B2-4909-B36C-72B183410B41Q37969667-FB04E163-B548-4E6D-B038-0895F52A9308Q38017604-8E8FF550-4D93-48E2-BF62-BCDF0C33496DQ40155667-330D114A-EF3D-44FC-B5BB-C3DEA49D6B3FQ41600452-0798798C-44D5-4662-AE84-9BA8C2DBE9A1Q47095893-31BD095A-E4C4-48EE-AF96-9176EEFD9068Q48430245-D8682A61-1EEB-45E7-A305-9F14C982E5CCQ50174554-34C875DF-D8CE-4682-99D6-3FD7CBC3676CQ50212352-08D3F9A3-BB62-4FFA-9A73-A7BE30437E40Q55030001-31EB78DC-23DB-4EEF-93E1-E905CA303179
P2860
Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of nodal status and tum ...... l outcomes of cancer patients.
@en
Impact of nodal status and tum ...... l outcomes of cancer patients.
@nl
type
label
Impact of nodal status and tum ...... l outcomes of cancer patients.
@en
Impact of nodal status and tum ...... l outcomes of cancer patients.
@nl
prefLabel
Impact of nodal status and tum ...... l outcomes of cancer patients.
@en
Impact of nodal status and tum ...... l outcomes of cancer patients.
@nl
P2093
P2860
P356
P1476
Impact of nodal status and tum ...... al outcomes of cancer patients
@en
P2093
Charles Levenback
Mark Faries
Markus Zuber
Ramon Cabanas
Stanley P L Leong
Sukamal Saha
Yuko Kitagawa
P2860
P304
P356
10.1002/JSO.21815
P577
2011-05-01T00:00:00Z